Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776203 · ClinicalTrials.gov registry record · Phase 4
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
A Phase 4 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT01776203 is a Phase 4 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 8 participants.
The verdict
NCT01776203, a Phase 4 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
In this study, the investigators would like to see if giving medroxyprogesterone acetate for 3 weeks after Leuprolide acetate injection will help to decrease this amount of bleeding, decrease the amount of nausea, bloating and cramping and increase patient satisfaction
Interventions
- DRUG Medroxyprogesterone 17-Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01776203
The ClinicalTrials.gov registry entry for NCT01776203 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medroxyprogesterone 17-Acetate is the first listed.
NCT01776203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01776203 about?
NCT01776203 is a clinical study titled "Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist". In this study, the investigators would like to see if giving medroxyprogesterone acetate for 3 weeks after Leuprolide acetate injection will help to decrease this amount of bleeding, decrease the amount of nausea, bloating and cramping and increase patient satisfaction
What is the current status of trial NCT01776203?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2012-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01776203?
The interventions under investigation include: Medroxyprogesterone 17-Acetate (DRUG).
Who is sponsoring clinical trial NCT01776203?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.